Cooperative Agreement HT94252520002
Award Date 9/1/25
Completion Date 8/31/30
Dollars Obligated $3.5M
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Research Triangle Park, Durham, NC, USA
Similar Awards
- This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $848,248 to the Research Triangle Institute (RTI International) to adapt behavioral activation approaches to improve mental health outcomes and reduce suicide risk during the military transition. The project will be conducted over a 3-year period from August 1, 2024 to July 31, 2027. RTI International, a prominent non-profit...
- This Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding a retrospective study on factors influencing alcohol treatment outcomes for U.S. Army personnel. The $901,042 award to the University of Texas at Austin, part of the University of Texas System, will analyze the role of personal, organizational, and treatment-related factors in shaping the outcomes of alcohol treatment programs for Army members...
- The Defense Health Agency awarded a $2.14 million project grant under the Military Medical Research and Development program (CFDA 12.420) to the Foundation For Advancing Veterans Health Research, a non-profit organization and foundation. The funding supports a randomized clinical trial evaluating the effectiveness of quetiapine in reducing polypharmacy among patients with post-concussive syndrome in San Antonio, TX. As a subrecipient, the Foundation also provides staffing, biostatistics,...
- The Defense Health Agency awarded a $1,999,583 Project Grant to IRR Inc. under the Military Medical Research and Development program (CFDA 12.420) to conduct an early-stage proof-of-concept study of a fixed-dose combination therapy in a high-fidelity porcine model of severe polytrauma. The performance period for this award runs from July 1, 2025 to June 30, 2027. The purpose of this federal grant is to transform healthcare for military service members, veterans, and the broader public through...
- The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public. Through this Cooperative Agreement, UTHSCSA will conduct research...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides funding to adapt an inhaled substance use intervention for adolescent and young adult cancer survivors. The $1,312,000.00 award, effective from August 1, 2025 to July 31, 2029, is being transferred from the University of Chicago to Ann and Robert H. Lurie Children's Hospital of Chicago to perform this research. The project aims to develop innovative medical...
- The Defense Health Agency awarded a $783,023 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "A PRECISION-MEDICINE APPROACH TO TARGETING ACQUIRED THERAPEUTIC RESISTANCE IN RTK-MUTATED NSCLC" over a 3-year period from June 1, 2025 to May 31, 2028. The Military Medical Research and Development program supports advanced...
- The Defense Health Agency awarded The Ohio State University a $8,375,496 cooperative agreement under the Military Medical Research and Development program (CFDA 12.420) from September 30, 2022 to September 29, 2026. This award will fund the Augmenting Suicide Prevention Interventions for Service Members project, which consists of five synergistic studies that aim to identify the strategies, delivery methods, providers, and circumstances most effective for preventing suicidality among military...
- The Defense Health Agency awarded a $1,397,266 project grant to The University of Queensland under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2023 through February 28, 2026 to develop peptide inhibitors targeting sodium channels for the treatment of Amyotrophic Lateral Sclerosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- The Defense Health Agency has awarded a $1.632 million Project Grant to the Ocean State Research Institute, Inc., a non-profit research organization, to investigate the long-term outcomes of antipsychotic medication use in U.S. veterans with post-traumatic stress disorder (PTSD). This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. As...